ARTICLE | Clinical News
Prurisol abacavir acetate: Completed Phase I enrollment
June 9, 2014 7:00 AM UTC
Cellceutix completed enrollment of about 18 healthy volunteers in a 2-part, open-label, crossover, U.S. Phase I bioequivalence trial to compare oral Prurisol vs. Ziagen abacavir sulfate. Subjects wil...